The SoCalBio Regulatory
Affairs Committee

Mission:

The Southern California Biomedical Council's Regulatory Affairs Committee serves as a forum for:

1. Networking among regulatory and clinical affairs professionals in the Greater Los Angeles region,

2. Providing educational seminars focusing on regulatory and clinical issues, and

3. Helping local firms, particularly startups, access resources to meet regulatory compliance requirements.

• To join the SoCalBio Regulatory Affairs Committee, your company has to be a SoCalBio member. Click here for membership application.

Committee Members (under construction):

• Marvin Garret, VP, Regulatory Affairs, Quality and Compliance, Ista Pharmaceuticals

• John Clapham, Pres. & CEO, Pharmaceutical Services Corporation

• Susan Bond, Regulatory Specialists, Inc. 

• R. J. O'Meara, Director, Global Legislative & Government Affairs, Beckman-Coulter Inc.

• Julie Finke, Sr. Director, Quality Assurance Diagnostics, Novartis Vaccines & Diagnostics

• Bob Mehta, Sr. Regulatory Compliance Manager, Edwards Lifesciences

• Michael Swit, Vice President, The Weinberg Group Inc.

• Syed Ali, QA Manager, Allergan

• Aiying Sun, Manager, Quality Assurance Validation, Siemens Healthcare Diagnostics

• Evan Siegel, M.Phil., Ph.D., President and CEO, Ground Zero Pharmaceuticals

• James Barquest, Ph.D., Director of Regulatory Affairs, Ground Zero Pharmaceuticals

• Kristin Houser, Director, Employee Training Institute, College of the Canyons

• Frances Richmond, Ph.D., Director, Regulatory Science Program, USC School of Pharmacy

• Prithul Bom, Account Executive, RCRI, Inc.
• Jennifer Marrone, Exec VP, RCRI, Inc.